Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPO-STROKE II: Triple Combination for Ischemic Stroke
NCT05762146Phase 2Unknown
- Sponsor
- Maastricht University
- Start
- Sep 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riociguat, propylthiouracil, Perphenazine in ischemic stroke, sponsored by Maastricht University. Status: unknown.
02
Drugs
riociguatpropylthiouracilPerphenazine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05762146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05762146.